As we move through 2026, the clinical landscape for radiation-induced skin injuries has undergone a fundamental transformation. What was once viewed as an unavoidable consequence of cancer treatment is now a primary focus of specialized oncology support. The Radiodermatitis Market research in 2026 indicates that the industry is being propelled by a "prevention-first" philosophy, where the goal...